|
Dean’s Distinguished Lecture Series |
Nancy Carrasco, MD, Professor and Chair, Department of Molecular Physiology & Biophysics; Joe C. Davis Chair in Biomedical Science, Vanderbilt University School of Medicine
- Community Lecture - Jan. 16, 2025, at 7 p.m. PT: "A Look Into the Black Box: Uncovering the Remarkable Biology of an Elusive Protein"
- Scientific Lecture - Jan. 17, 2025, at Noon PT: "The Tale of the Sodium/Iodide Symporter (NIS): From Cloning to Structure"
Learn more about the Dean’s Distinguished Lecture Series.
Jan. 16–17, 2025 Location: The Beckman Center, Irvine, Calif. (Jan. 16); UCI Medical Education Building, Irvine, Calif. (Jan. 17)
|
|
Join us for Bringing Biology to the Patient: A Collaborative Faculty Retreat | You’re invited to attend Bringing Biology to the Patient: A Collaborative Faculty Retreat with the UCI School of Medicine and the UCI Charlie Dunlop School of Biological Sciences. All event details, including the agenda, can be found on the Faculty Research Retreat website.
Thursday, Feb.13, 2025, 9 a.m. to 6 p.m Location: Beall Applied Innovation
|
|
Register for one of the upcoming UCI NIH Boot Camp Informational Sessions | The Research Development Unit will host three virtual informational sessions about the UCI NIH Boot Camp, a comprehensive, multifaceted mentoring program designed to help faculty and career researchers apply for their first research grants from NIH. Attend one to learn more about this program and how to apply for the upcoming 2025 UCI NIH Boot Camp! Applications are due Feb. 10, 2025.
- Thursday, Dec. 19, 2024, Noon to 1 p.m. | Register
- Thursday, Jan. 9, 2025, Noon to 1 p.m. | Register
- Thursday, Jan. 23, 2025, 9 to 10 a.m. | Register
|
|
FDA Clinical Investigator Training Course (CITC) 2024: A No-Cost Virtual Conference | Gain the essential knowledge and skills to conduct clinical trials effectively, ethically and in accordance with regulatory standards.
- Day 1: Tuesday, Dec. 10, 8 a.m. to 12:30 p.m.
- Day 2: Wednesday, Dec. 11, 8 a.m. to 1 p.m.
- Day 3: Thursday, Dec.12, 8 a.m. to 12:05 p.m.
|
|
Preparing for 2025 NIH Application and Review Changes – Tips and Resources | NIH has issued a reminder that multiple changes affecting extramural applications and review are coming for application due dates on or after Jan. 25, 2025. As you prepare applications for the January due dates and beyond, NIH has provided a few more updates, tips, and resources. Hopefully, you were already aware of these changes, which include:
|
|
MS-BATS Program Now Open: Excel as an Effective Clinical Researcher with a Degree in Biomedical and Translational Science | The Master of Science in Biomedical and Translational Science (MS-BATS) program trains students to conduct high-quality multidisciplinary clinical research at the intersection of basic science and clinical medicine.
Students from various training backgrounds, including medical students, residents, fellows, physicians, nurses and others interested in excelling as an effective clinical researcher will benefit from this program. Students will have the opportunity to develop their own individual research project under faculty mentorship to advance their career goals. Learn more and apply.
Deadline: May 30, 2025 |
|
Cancer Clinical Trial Bootcamp | The Chao Family Comprehensive Cancer Center is accepting applications for the Cancer Clinical Trial Bootcamp, an intensive 16-week program that equips clinical faculty and fellows with the skills to systematically design and write investigator-initiated cancer clinical trial protocols. By the program's conclusion, participants will submit a fully developed protocol. Learn more and apply by Jan. 14, 2025.
Program Dates: Feb. 26–June 4, 2025, every other Wednesday, 6 to 8 p.m. Application Deadline: Jan. 14, 2025
|
|
| Anand Ganesan, MD, PhD (Dermatology), received a three-year $600k grant from the LEO Foundation for his project titled, “ Identifying New, Molecularly-targeted Treatments for Rosacea.” This project investigates the role of RhoJ and CDC42 GTPase signaling in the development of rosacea, focusing on the activation of the innate immune system and increased blood vessel formation. By employing single cell and spatial transcriptomics, the research aims to identify rosacea-inducing signals and evaluate the effectiveness of new CDC42 inhibitors in preventing angiogenesis, with the ultimate goal of discovering new drug targets and treatments for rosacea. Do you or someone on your team have research-related good news to report (e.g., research funding/award, publication, other accolade)? We would like to know! Please fill out this short Good News submission form. |
|
| Find funding opportunities for trainees, postdocs and early career faculty, and all faculty.
For more funding opportunities and resources to help in your funding search, visit the Funding Opportunities page.
For a curated, searchable and filterable list of funding opportunities announced by NIH in their weekly NIH guide listserv, check out the School of Medicine Funding Search Tool.
Considering applying for a Limited Funding Opportunity? Typically, you submit a pre-proposal to the Office of Research via UCI Review. If the opportunity is not listed, email the Research Development Unit (RDU). |
|
Postdocs & Early Career Faculty Funding Opportunities |
Limited: Ono Pharma Foundation Breakthrough Science Initiative Awards Program | Ono Pharma Foundation was established to support academic research in relevant scientific fields which have the potential for significant impact on therapeutic approaches to disease and pain management. Proposals must address Chemical Biology Research, defined as research at the interface between chemistry and biology. They are especially looking for unique chemistry tools that can be used to answer biological questions related to human health and disease. A project duration may last up to three years with annual funding of $300,000/year, totaling $900,000 for the normal term of a research project.
Eligibility: The PI must have 15 years of experience or fewer since starting independent academic position. Review the posting for more eligibility requirements.
Deadline: Jan. 6, 2025 UCI may submit two applications for this award opportunity; thus interested applicants are asked to submit a preliminary application via UCI Review. |
|
Limited: Damon Runyon Clinical Investigator Award | The Damon Runyon Clinical Investigator Award supports independent young physician-scientists conducting disease-oriented research that demonstrates a high level of innovation and creativity. The goal is to support the best young physician-scientists doing work aimed at improving the practice of cancer medicine. The $600,000 award will be for a period of three years. Funding in the amount of $200,000 will be allocated to the awardee’s institution each year for the support of the Clinical Investigator. Funds are intended to be flexible and can be used for a variety of scientific needs including the Investigator’s stipend and/or fringe benefits (up to $130,000 annually), salaries for professional and technical personnel, special equipment, supplies, and other miscellaneous items required to conduct the proposed research. No part of this grant can be used for indirect costs or institutional overhead. Read more.
Eligibility: The applicant must hold an independent Assistant Professor position or equivalent and is expected to demonstrate significant support from the home institution through a comprehensive start-up package, ample laboratory space, and protected research time, for example.
Deadline: Feb. 3, 2025 Five nominations per institution are allowed; interested applicants should contact Roxanne Ford, Executive Director, Corporate and Foundation Relations.
|
|
All Faculty Funding Opportunities |
Newly released ARPA-H Funding Announcements | The Advanced Research Projects Agency for Health (ARPA-H) has significant funding to accelerate biomedical and health research that cannot be readily accomplished through traditional research or commercial activity. This ARPA submission resources/FAQ webpage provides useful resources, templates and links to help you understand the details of the process, from initial submission to a final awarded agreement. Slides from “Doing Business with ARPA-H” include the ARPA-(H)eilmeier Questions (slide 13), which are imperative to answer in all proposals
McAllister & Quinn hosted a comprehensive informational webinar on Advanced Research Projects Agency for Health (ARPA-H) on Oct. 29, 2024. The materials (slide deck, agency engagement guide and recording) are available on the School of Medicine Office of Research webinar recordings webpage. Your UCINetID login is required to view the page.
Active programs:
- Emerging Health Innovators Initiative | Virtual Proposers’ Day: Jan. 8, 2025 (Registration deadline: Jan. 6, 2025)
- ImagiNg Data EXchange (INDEX) | Proposers’ Day: Jan. 9, 2025 (in-person in Seattle, Wash., or virtual, registration deadline: Jan. 2, 2025) | Solution Summaries Due: Jan. 23, 2025
- Ocular Laboratory for Analysis of Biomarkers (OCULAB) | ARPA-H | Proposers’ Day: Dec. 11, 2024
- About the Advancing Clinical Trial Readiness (ACTR) Initiative | Proposers’ Day: Jan. 16, 2025 (in-person in New Brunswick, New Jersey, registration deadline: Jan. 9, 2025; or virtual, registration deadline: Jan. 14, 2025)
If you are considering applying, please email somrd@hs.uci.edu. |
|
Limited: 2024-25 Mary Kay Ash Foundation® Research Grant | The Mary Kay Ash Foundation is a nonprofit public foundation, which focuses on funding research for innovative grants for translational research of cancers affecting women (ovarian, uterine, breast, endometrial or cervical cancer among others). Translational research is broadly defined as research that will provide a scientific link between laboratory research and the clinic. Such research would lead to improvement in diagnosis, prognosis, prevention, or treatment of the cancer. The grant will be up to $100,000 (combined direct and indirect costs) for a two-year period.
The campus may submit one application; therefore, interested applicants should apply via UCI Review.
Deadline: Friday, Dec. 13, 2024 |
|
AI Science at Scale Request for Proposals | The University of California (UC) system, in partnership with NNSA laboratories, is seeking proposals from UC researchers for collaborative projects that advance the frontiers of Artificial Intelligence and Machine Learning at scale. The central goal is to bring together the intellectual power of the UC system, including 10 leading public research universities and three national laboratories, and develop scientific AI projects that benefit from computational scale while also harnessing the power of interdisciplinary AI and science and engineering research and expertise.
Technical focus areas: Multiphysics Applications | Biological Systems | Materials Discovery. Learn more and apply.
Deadline: Friday, Dec. 20, 2024
|
|
Limited: W.M. Keck Foundation Research Program Grants | In reviewing proposals, the W.M. Keck Foundation asks, “What’s the new science?” Concept papers should provide a compelling argument that new knowledge discovery on a specific question will result from the proposed project. UCI has had remarkable success with this foundation. Grantee teams include Chang Liu; Max Plikus, Andrej Luptak, Jennifer Prescher and Os Steward; Rob Spitale and John Chaput; Filippo Capolino and Eric Potma; Derek Dunn-Rankin; John Hemminger; Tony James; Enrico Gratton and Michelle Digman; and Kumar Wickramasinghe. Budget requests may be for up to $1.5 million and may be expended over three years. The Keck Foundation does not pay indirect costs, nor does it allow for tuition and fees for graduate students.
UCI may nominate two applications; thus, interested applicants are asked to submit a preliminary concept paper via UCI Review.
Deadline: Monday, Jan. 6, 2025 |
|
2024–25 UCI Center-Scale Multi-Investigator Research Seed Funding Program | The 2024–25 UCI Center-Scale Multi-Investigator Research Seed Funding Program is aimed at investing in promising convergent research directions where internal seed level investment can lead to externally funded “center-scale” research programs. UC Irvine faculty members who are eligible to serve as Principal Investigators may apply. Only multi-investigator, multidisciplinary teams and proposals are eligible. Seed funding may be requested for a period of up to two years, and it is anticipated that 5–8 awards of up to $150,000 each will be given. Apply here via UCI Review.
Deadline: Tuesday, Jan. 14, 2025
|
|
Cancer Research Coordinating Committee (CRCC) 2025-26 Faculty Seed Grants | The CRCC is a systemwide, faculty-directed cancer research program that provides one-year seed grants for topics in any discipline that address any aspect of cancer, including its origins, prevention and cure. CRCC funds support meritorious research spanning all areas, from basic research to applied clinical and community-based research in any field relevant to cancer. Applications in disciplines outside of basic and clinical/translational science are welcome (e.g., public health, law, social sciences, psychology, health services research, community-based research, implementation science). See Request for Proposals (PDF).
Eligibility: PIs must be members of the Academic Senate at one of the 10 UC campuses.
There will be two applicant webinars: Attendance is highly recommended if you are a first-time applicant and/or new to SmartSimple.
Required Letters of Intent Deadline: Thursday, Jan. 23, 2025, by 12 p.m. |
|
Upcoming Seminars & Events |
Physiology & Biophysics Seminar Series | From a Cone-Specific Visual Cycle to Preventing Retinal Degeneration, by Vladimir Kefalov, PhD, Professor, Department of Ophthalmology, UCI School of Medicine
Wednesday, Dec. 11, 4 to 5 p.m. Location: Hybrid event at Plumwood House Lecture Hall and via Zoom Contact Claire Chen to join via Zoom. |
|
Standardize Your Research Data with the NIH Common Data Element Repository | Through live demonstrations and hands-on exercises, this course will introduce you to common data elements (CDEs) and the NIH Common Data Element Repository (CDE-R). The course begins with an in-depth introduction to what CDEs are and examples of how researchers are already using them. Then, you’ll see how to search the repository and practice searching on your own. Subject matter experts will be in attendance to answer your questions.
Thursday, Dec. 12, 10 to 11:30 a.m. Via Zoom
|
|
Center for Translational Vision Research (CTVR) Distinguished Speaker Series |
Melanopsin from Molecule to Behavior, by Phyllis R. Robinson, PhD, Professor, Department of Biological Sciences, College of Natural and Mathematical Sciences, University of Maryland, Baltimore County. Learn more on CTVR's event page.
Friday, Dec. 13, 8:30 to 10 a.m. Location: Hybrid event at the Gavin Herbert Eye Institute, 3rd Floor Cavanaugh Room, or via Zoom
|
|
UCI Gavin Herbert Eye Institute Vision Research Mixer | Please join us for an opportunity to hear from UCI vision scientists at the Vision Research Mixer. RSVP to ophthalmology@uci.edu.
4:30 to 5:30 p.m. – Research Presentations 5:30 to 6:30 p.m. – Networking & Reception
Wednesday, Dec. 18, 4:30 to 6:30 p.m. Location: Gross Hall, 4th Floor Conference Room
|
|
Stem Cell Seminar Lecture Series | Human Kidney Organoids for Disease Modeling and Regeneration, by Benjamin Freedman, PhD, Associate Professor, Division of Nephrology, University of Washington School of Medicine. Hosted by the UCI Sue & Bill Gross Stem Cell Research Center.
Friday, Dec. 20, 1 to 2 p.m. Location: Gross Hall, Thorp Conference Center (4th Floor)
|
|
Monthly on Mondays | Faculty Development Series | Merits and Promotions for HS Clinical and Senate Faculty, presented by Brian Cummings, PhD, and Mohammad Helmy, MD. Monthly on Mondays, presented by Nimisha Parekh, MD, and Brian Cummings, PhD, associate deans of faculty development, is a monthly seminar series covering a wide range of topics focused on faculty development.
Monday, Jan. 13, 5:15 to 6:15 p.m. Via Zoom
|
|
CHOC and UCI Rare Disease Symposium & Family Conference: Abstract Submissions Open! | The Fourth Annual CHOC and UCI Rare Disease Symposium & Family Conference will focus on the latest innovations in the diagnosis and treatment of rare diseases across various specialties. Attendees will experience dynamic presentations by leading experts, as well as personal stories from families affected by rare conditions, promoting a stronger sense of community and understanding.The abstract submission deadline is Monday, Jan. 13, 2025.
Friday, Feb. 28, 2025, 8 a.m. to 5 p.m. PT Location: Beckman Center of the National Academies of Sciences & Engineering, Irvine, Calif. |
|
CHOC Research Institute: Pediatric and Lifespan Data Science Conference: Abstract submissions now open! | Join CHOC for the second Pediatric and Lifespan Data Science Conference! This event will explore the intersection of precision medicine and artificial intelligence, suicide prediction and the management of complex medical patients. Perspectives from patients, families, healthcare providers, health systems, data scientists and insurance companies will be featured.
Abstract Submission Deadline: Feb. 3, 2025 | Submit Abstract Early Bird Registration Deadline: Feb. 3, 2025 | Register
April 10–11, 2025 Location: The Westin Anaheim Resort |
|
Inaugural MAXImizing Training in MUScle Research (MAXIMUS) Retreat: Abstract submission now open! | The UCI Muscle Biology and Disease Research Center presents the Inaugural MAXIMUS Retreat centered on cutting-edge work in mechanisms and therapeutics of neuromuscular diseases. Activities will include talks from invited leaders in the field, current MAXIMUS awardees, and selected abstracts from UCI trainees, a career panel luncheon, and a poster session with awards. Additionally, a seed grant funding opportunity for trainees will be announced at the event.
Highlighted speakers: Tom Lloyd (Baylor College of Medicine), Alessandra Sacco (Sanford Burnham Prebys) and Stephen Tapscott (Fred Hutchinson Cancer Center)
Students, postdocs, and clinical fellows are encouraged to showcase their work by presenting a poster/talk:
- Abstract submission deadline (short talk): Jan. 21, 2025
- Abstract submission deadline (poster only): March 29, 2025
April 10, 2025, 8:45 a.m. to 5:30 p.m. Location: Interdisciplinary Science and Engineering Building (ISEB) Auditorium 1010
|
|
Junior Specialist | The Ezzati Lab is seeking a Junior Specialist with a background in neuroscience, public health, data science or related fields to join their interdisciplinary team for research in the field of headache disorders.
PI: Ali Ezzati, MD View the posting in AP Recruit. Closing Date: Dec. 31, 2024
|
|
| Do you have an open research-related position you would also like announced in Research Insider? Please fill out this form to have your open position listed.
|
|
NIH All About Grants Podcast: Growing ORCIDs | Similar to what NIH-supported trainees and fellows must do, senior and key personnel designated on NIH grant applications will be required to have an ORCID (Open Researcher and Contributor Identification) linked to their eRA Commons profile in May 2025. Dr. Bart Trawick, who leads the Customer Services Section within the National Library of Medicine’s National Center for Biotechnology Information, will tell us the benefits of growing ORCIDs in the scientific community in this episode. Read more.
|
|
School of Medicine Research Development Unit Resources |
What kind of grant support does the RDU provide? | |
|
What kind of grant support does the RDU provide to Physician Scientists? | Along with the general grant support the RDU provides (outlined above), there are multiple programs available outlined on the Physician Scientist Resources page. - Physician Scientist Collective: Monthly seminar series with visiting speakers
- Physician Scientist Pathways Certificate Course: Six-week, 12-hour hybrid course that introduce clinicians to research pathways
- Physician Scientist Training Program (PSTP): Helps physician scientists apply for their first K award
- Dean’s K Scholar: Provides awardees the protected time and mentorship needed to obtain NIH K/ equivalent funding
- Clinical Trialist Training Program (CTTP): Supports junior faculty on externally funded clinical trials through a 2-year partnership program with senior investigators already running clinical trials
|
|
Contribute to Research Insider! |
| |
|